Apollo and Sofinnova Partners (Sofinnova), a European life sciences venture capital firm based in Paris, London, and Milan, have formed a long-term strategic and financial partnership.
Under the agreement, Apollo will take a minority equity interest in Sofinnova and commit up to €1 billion of managed capital to its investment funds.
This strategic partnership is poised to significantly accelerate Sofinnova’s growth. For Apollo, the investment will meaningfully increase its presence in life sciences and contribute to its growth ecosystem of partners that bring specialised knowledge and networks to its integrated platform.
